{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T04:27:21Z","timestamp":1777004841447,"version":"3.51.4"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.ejmech.2021.113966","type":"journal-article","created":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T11:11:18Z","timestamp":1635765078000},"page":"113966","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Novel nucleocapsid protein-targeting phenanthridine inhibitors of SARS-CoV-2"],"prefix":"10.1016","volume":"227","author":[{"given":"Yi-Ting","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-Yan","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3287-7611","authenticated-orcid":false,"given":"Xiao","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi-Rui","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie-Yun","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bi-Juan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-Fang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong-hua","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen-Xu","family":"Jing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Tang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Jiang","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duo-Zhi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2021.113966_bib1","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1126\/science.abc1560","article-title":"Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir","volume":"368","author":"Yin","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2021.113966_bib2","doi-asserted-by":"crossref","first-page":"115745","DOI":"10.1016\/j.bmc.2020.115745","article-title":"Druggable targets from coronaviruses for designing new antiviral drugs","volume":"28","author":"Silva","year":"2020","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113966_bib3","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2021.113966_bib4","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2021.113966_bib5","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.csbj.2021.01.032","article-title":"Current concepts in the development of therapeutics against human and animal coronavirus diseases by targeting NP","volume":"19","author":"Tseng","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.ejmech.2021.113966_bib6","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.drudis.2015.11.015","article-title":"Recent insights into the development of therapeutics against coronavirus diseases by targeting N protein","volume":"21","author":"Chang","year":"2016","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2021.113966_bib7","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.apsb.2020.04.009","article-title":"Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites","volume":"10","author":"Kang","year":"2020","journal-title":"Acta Pharm. Sin. B."},{"key":"10.1016\/j.ejmech.2021.113966_bib8","doi-asserted-by":"crossref","first-page":"12359","DOI":"10.1021\/acs.jmedchem.0c00606","article-title":"COVID-19: drug targets and potential treatments","volume":"63","author":"Gil","year":"2020","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113966_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15252\/embj.2020105938","article-title":"Structures of the SARS-CoV-2 nucleocapsid and their perspectives for drug design","volume":"39","author":"Peng","year":"2020","journal-title":"EMBO J."},{"key":"10.1016\/j.ejmech.2021.113966_bib10","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02236-06","article-title":"Ribonucleocapsid formation of severe acute respiratory syndrome coronavirus through molecular action of the N-terminal domain of N protein","volume":"81","author":"Saikatendu","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ejmech.2021.113966_bib11","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.jmb.2009.09.040","article-title":"Coronavirus N protein N-terminal domain (NTD) specifically binds the transcriptional regulatory sequence (TRS) and melts TRS-cTRS RNA duplexes","volume":"394","author":"Grossoehme","year":"2009","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.ejmech.2021.113966_bib12","doi-asserted-by":"crossref","first-page":"4816","DOI":"10.1093\/nar\/gkl650","article-title":"Amino acid residues critical for RNA-binding in the N-terminal domain of the nucleocapsid protein are essential determinants for the infectivity of coronavirus in cultured cells","volume":"34","author":"Tan","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2021.113966_bib13","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1021\/jm500089r","article-title":"Structural basis for the identification of the N-terminal domain of coronavirus nucleocapsid protein as an antiviral target","volume":"57","author":"Lin","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113966_bib14","doi-asserted-by":"crossref","first-page":"561","DOI":"10.4155\/fmc.15.14","article-title":"Lycorine-derived phenanthridine downregulators of host Hsc70 as potential hepatitis C virus inhibitors","volume":"7","author":"Chen","year":"2015","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113966_bib15","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1021\/acs.jnatprod.0c01252","article-title":"Phenanthridine derivative host heat shock cognate 70 down-regulators as Porcine Epidemic Diarrhea Virus inhibitors","volume":"84","author":"Chen","year":"2021","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2021.113966_bib16","unstructured":"C. Chang, K. Michalska, R. Jedrzejczak, N. Maltseva, M. Endres, A. Godzik, Y. Kim, A. Joachimiak, Crystal structure of RNA Binding Domain of Nucleocapsid Phosphoprotein from SARS Coronavirus 2, (To be published ) 10.2210\/pdb2216VYO\/pdb."},{"key":"10.1016\/j.ejmech.2021.113966_bib17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3390\/molecules26010057","article-title":"Blocking effect of demethylzeylasteral on the interaction between human ACE2 protein and SARS-CoV-2 RBD protein discovered Using SPR technology","volume":"26","author":"Zhu","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2021.113966_bib18","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"Software news and update AutoDock vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.ejmech.2021.113966_bib19","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.ejmech.2021.113966_bib20","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1021\/acs.jmedchem.9b01913","article-title":"Structure-Based stabilization of non-native protein-protein interactions of coronavirus nucleocapsid proteins in antiviral drug design","volume":"63","author":"Lin","year":"2020","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113966_bib21","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/bs.mie.2018.09.015","article-title":"A\u00a0Guide to run affinity screens using differential Scanning Fluorimetry and Surface Plasmon Resonance assays","volume":"610","author":"Bergsdorf","year":"2018","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ejmech.2021.113966_bib22","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1126\/science.abf1611","article-title":"SARS-CoV-2 Mpro inhibitors with antiviral activity in a transgenic mouse model","volume":"371","author":"Qiao","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2021.113966_bib23","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1039\/C5MB00582E","article-title":"Structure-based virtual screening and experimental validation of the discovery of inhibitors targeted towards the human coronavirus nucleocapsid protein","volume":"12","author":"Chang","year":"2016","journal-title":"Mol. Biosyst."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421008151?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421008151?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:41:48Z","timestamp":1759329708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523421008151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":23,"alternative-id":["S0223523421008151"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113966","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel nucleocapsid protein-targeting phenanthridine inhibitors of SARS-CoV-2","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113966","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113966"}}